Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Holdings for S&L as of 8/31/2007
2
Dec 20, 2007 05:28AM
11
Dec 20, 2007 05:39AM
5
Dec 20, 2007 05:49AM
2
Dec 20, 2007 06:02AM
1
Dec 20, 2007 06:14AM

Dec 20, 2007 06:17AM

Dec 20, 2007 06:20AM
1
Dec 20, 2007 06:37AM
1
Dec 20, 2007 06:40AM
1
Dec 20, 2007 06:44AM

Dec 20, 2007 06:50AM

Dec 20, 2007 06:51AM

Dec 20, 2007 07:13AM

Dec 20, 2007 12:13PM

Dec 20, 2007 12:36PM
Lincoln Ventures, LLC 29,624,189 (8)
7.61%
Swartz Private Equity, LLC
5,759,940 (8)
1.48%

Includes 5,000,000 shares issuable upon the exercise of warrants. The documents governing Lincoln Ventures, LLC’s (“Lincoln”) warrants contain a provision prohibiting Lincoln from exercising warrants for shares of Common Stock if doing so would result in it and its affiliates beneficially owning shares of Common Stock representing more than 9.99% of the outstanding shares of Common Stock as determined under Section 13(d) of the Securities Exchange Act of 1934. If Swartz Private Equity LLC (“Swartz”) were determined to be an affiliate of Lincoln, then Lincoln’s exercisable warrant position would be reduced to the extent necessary to limit the combined beneficial ownership of Lincoln and Swartz to 9.99% of the Company’s outstanding Common Stock.

from 10-Q

As of August 31, 2007, we had warrants outstanding to purchase 9,935,915 common shares at exercise prices ranging from $0.05 to $1.00 per share, expiring at various dates through 2012. Some of those outstanding warrants were not exercisable as of August 31, 2007 as they are subject to meeting vesting criteria. During the three months ended August 31, 2007, we issued no warrants to purchase shares of common stock, an investor exercised warrants to purchase 125,000 shares of common stock for proceeds of $6,250 and we repurchased 2,000,000 warrants for $921,857 under terms of our warrant repurchase agreement as detailed below.

Now subtract the 5 million warrants that Turley bought back since then

On September 4, 2007, we repurchased 2,000,000 warrants for $799,647 pursuant to the terms of our warrant repurchase agreement with Lincoln Ventures, LLC.

On October 2, 2007, we repurchased the remaining 3,000,000 warrants for $1,039,398 pursuant to the terms of our warrant repurchase agreement with Lincoln Ventures, LLC

So S&L still have approximately 30 million all shares, no warrants and no convertible.


Dec 20, 2007 03:45PM
2
Dec 20, 2007 04:47PM
1
Dec 20, 2007 06:31PM
1
Dec 21, 2007 09:54AM
Share
New Message
Please login to post a reply